Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1800-0.0200 (-1.67%)
At close: 04:00PM EDT
1.2000 +0.02 (+1.69%)
After hours: 07:10PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/2/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.6200
52 Week Low 30.6400
50-Day Moving Average 31.3702
200-Day Moving Average 32.0552

Share Statistics

Avg Vol (3 month) 33.89M
Avg Vol (10 day) 32.22M
Shares Outstanding 5171.01M
Implied Shares Outstanding 6N/A
Float 8170.73M
% Held by Insiders 11.20%
% Held by Institutions 193.95%
Shares Short (Jul 14, 2022) 410.45M
Short Ratio (Jul 14, 2022) 41.4
Short % of Float (Jul 14, 2022) 47.13%
Short % of Shares Outstanding (Jul 14, 2022) 46.07%
Shares Short (prior month Jun 14, 2022) 47.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:9
Last Split Date 3Jun 24, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -109.56%
Operating Margin (ttm)-109.09%

Management Effectiveness

Return on Assets (ttm)-28.93%
Return on Equity (ttm)-199.44%

Income Statement

Revenue (ttm)77.45M
Revenue Per Share (ttm)0.45
Quarterly Revenue Growth (yoy)-78.50%
Gross Profit (ttm)72.42M
EBITDA -83.43M
Net Income Avi to Common (ttm)-84.86M
Diluted EPS (ttm)-0.1760
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)107.52M
Total Cash Per Share (mrq)0.62
Total Debt (mrq)97.34M
Total Debt/Equity (mrq)1,431.94
Current Ratio (mrq)2.35
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)196k
Levered Free Cash Flow (ttm)81.86M
Advertisement
Advertisement